Published in PLoS One on December 29, 2014
Cystoisospora suis - A Model of Mammalian Cystoisosporosis. Front Vet Sci (2015) 0.78
The genome of the protozoan parasite Cystoisospora suis and a reverse vaccinology approach to identify vaccine candidates. Int J Parasitol (2017) 0.76
Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol (2001) 66.87
BLAST+: architecture and applications. BMC Bioinformatics (2009) 36.53
SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods (2011) 33.90
Locating proteins in the cell using TargetP, SignalP and related tools. Nat Protoc (2007) 19.50
A combined transmembrane topology and signal peptide prediction method. J Mol Biol (2004) 15.77
Toxoplasmosis. Lancet (2004) 13.96
WoLF PSORT: protein localization predictor. Nucleic Acids Res (2007) 10.14
The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol (2005) 7.40
Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci (2003) 5.94
Scoring residue conservation. Proteins (2002) 4.66
A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol (2006) 4.52
A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol (2006) 3.73
A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol (2008) 3.71
NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics (2008) 3.59
Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics (2005) 2.91
Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. Infect Immun (2001) 2.68
Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol (2008) 2.30
Reverse vaccinology: developing vaccines in the era of genomics. Immunity (2010) 2.25
Toxoplasma gondii: the model apicomplexan. Int J Parasitol (2004) 2.10
Evasion of innate immunity by parasitic protozoa. Nat Immunol (2002) 2.08
Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res (2008) 2.07
Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun (2002) 1.94
Reverse vaccinology, a genome-based approach to vaccine development. Vaccine (2001) 1.82
Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine (2010) 1.61
Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat Struct Mol Biol (2011) 1.48
Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines. BMC Bioinformatics (2007) 1.47
Bridging the knowledge gaps in vaccine design. Nat Biotechnol (2007) 1.39
Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun (1999) 1.26
Search for potential vaccine candidate open reading frames in the Bacillus anthracis virulence plasmid pXO1: in silico and in vitro screening. Infect Immun (2002) 1.26
Human leukocyte antigen gene polymorphism and the histocompatibility laboratory. J Mol Diagn (2001) 1.25
Methods and protocols for prediction of immunogenic epitopes. Brief Bioinform (2006) 1.19
Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. Vaccine (2001) 1.19
Computer-aided biotechnology: from immuno-informatics to reverse vaccinology. Trends Biotechnol (2008) 1.13
Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii. Infect Immun (2009) 1.10
Genome-based approaches to develop vaccines against bacterial pathogens. Vaccine (2009) 1.07
Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201. Vaccine (2010) 1.04
Comprehensive proteomic analysis of membrane proteins in Toxoplasma gondii. Mol Cell Proteomics (2010) 1.00
Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii. Vaccine (2008) 0.96
Computer aided selection of candidate vaccine antigens. Immunome Res (2010) 0.95
Antigenicity and immunogenicity of P30-derived peptides in experimental models of toxoplasmosis. Mol Immunol (1994) 0.95
Evolution of the Apicomplexa: where are we now? Trends Parasitol (2009) 0.95
Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-γ and reduces parasite burden in HLA-B*0702 mice. Hum Immunol (2011) 0.94
A guide to in silico vaccine discovery for eukaryotic pathogens. Brief Bioinform (2012) 0.93
A comparative study of conservation and variation scores. BMC Bioinformatics (2010) 0.91
A novel strategy for classifying the output from an in silico vaccine discovery pipeline for eukaryotic pathogens using machine learning algorithms. BMC Bioinformatics (2013) 0.89
Genetics. Themes and variations in apicomplexan parasite biology. Science (2005) 0.88
Statistical comparison of established T-cell epitope predictors against a large database of human and murine antigens. Mol Immunol (1996) 0.85
Sarcocystis neurona major surface antigen gene 1 (SAG1) shows evidence of having evolved under positive selection pressure. Parasitol Res (2004) 0.83
Molecular evolution of serine/arginine splicing factors family (SR) by positive selection. In Silico Biol (2006) 0.83
Population genetics and natural selection in the gene encoding the Duffy binding protein II in Iranian Plasmodium vivax wild isolates. Infect Genet Evol (2013) 0.82
Age-dependent impairment of functional helper T cell responses to immunodominant epitopes of Toxoplasma gondii antigens in congenitally infected individuals. Microbes Infect (2006) 0.81
Correlation between direct binding ability of synthetic T. gondii SAG1 peptides to HLA-A2 measured by a sensor for surface plasmon resonance and antigenicity of the peptides for T. gondii-infected cell-specific CTL. Biochem Biophys Res Commun (1997) 0.80
T cell mediated immune responses to Toxoplasma gondii in pregnant women with primary toxoplasmosis. Microbes Infect (2005) 0.79
Systemic T cell response to Toxoplasma gondii antigen in patients with ocular toxoplasmosis. Jpn J Ophthalmol (2006) 0.79